Pages that link to "Q36056325"
Jump to navigation
Jump to search
The following pages link to Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments (Q36056325):
Displaying 50 items.
- NCK2 is significantly associated with opiates addiction in African-origin men (Q21284775) (← links)
- Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system (Q22242415) (← links)
- Khat use and neurobehavioral functions: suggestions for future studies (Q24610235) (← links)
- Stress, dysregulation of drug reward pathways, and the transition to drug dependence (Q24629577) (← links)
- Genetic susceptibility to heroin addiction: a candidate gene association study (Q24634090) (← links)
- The neurobiology and genetics of impulse control disorders: relationships to drug addictions (Q24642641) (← links)
- An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research (Q26829172) (← links)
- κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction (Q26864309) (← links)
- The genetics of substance dependence (Q27002251) (← links)
- Long-Term Effects of Chronic Khat Use: Impaired Inhibitory Control (Q27500430) (← links)
- Drugs for pain management in dentistry (Q28194546) (← links)
- Association of the kappa-opioid system with alcohol dependence (Q28259296) (← links)
- Symbiotic relationship of pharmacogenetics and drugs of abuse. (Q28476270) (← links)
- Genome-Wide Association of Heroin Dependence in Han Chinese (Q28554877) (← links)
- Epigenetic regulation in psychiatric disorders (Q29616296) (← links)
- Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready? (Q30229059) (← links)
- Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. (Q31008696) (← links)
- Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction (Q31039070) (← links)
- Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases (Q33643136) (← links)
- Advances in genetic studies of substance abuse in China (Q33744466) (← links)
- The Genetics, Neurogenetics and Pharmacogenetics of Addiction (Q33898930) (← links)
- Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response (Q33903933) (← links)
- Pharmacotherapy in the treatment of addiction: methadone (Q33914167) (← links)
- A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions (Q34037595) (← links)
- Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome (Q34090556) (← links)
- Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity (Q34091475) (← links)
- Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. (Q34165511) (← links)
- Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? (Q34358797) (← links)
- Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent (Q34410506) (← links)
- Caudate Volume in Offspring at Ultra High Risk for Alcohol Dependence: COMT Val158Met, DRD2, Externalizing Disorders, and Working Memory (Q34429452) (← links)
- Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction (Q34463235) (← links)
- Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse (Q34528040) (← links)
- Pharmacogenetics and the concept of individualized medicine (Q34562770) (← links)
- Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts (Q34656790) (← links)
- Haplotype block structure of the genomic region of the mu opioid receptor gene (Q34786964) (← links)
- Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding affinities at the dopamine D1 receptor. (Q34843018) (← links)
- Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1) (Q34939590) (← links)
- Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study (Q35005588) (← links)
- Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors (Q35007339) (← links)
- A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women (Q35050878) (← links)
- Quantitative Detection of µ Opioid Receptor: Western Blot Analyses Using µ Opioid Receptor Knockout Mice (Q35107830) (← links)
- Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty (Q35195803) (← links)
- Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder (Q35196495) (← links)
- Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice (Q35199976) (← links)
- Regional brain [(11)C]carfentanil binding following tobacco smoking (Q35222619) (← links)
- Genotyping test with clinical factors: better management of acute postoperative pain? (Q35381687) (← links)
- Gray matter abnormalities associated with betel quid dependence: a voxel-based morphometry study (Q35440181) (← links)
- Pharmacogenetic aspects of addictive behaviors (Q35454787) (← links)
- Opioids, dopamine, stress, and the addictions. (Q35454821) (← links)
- Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach (Q35599801) (← links)